Clover Health Investments Corp. [NASDAQ: CLOV] closed the trading session at $0.96 on 12/19/22. The day’s price range saw the stock hit a low of $0.955, while the highest price level was $1.07. The company report on December 13, 2022 that Clover Health Issues December 2022 Investor Frequently Asked Questions.
Will You Miss Out On This Growth Stock Boom?
A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.
And this is just one of our 5 Best Growth Stocks To Own For 2023.
Forward-Looking StatementsPlease note that our responses contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include statements regarding future events and Clover Health’s future plans. Forward-looking statements are not guarantees of future performance, and you are cautioned not to place undue reliance on such statements. Additional information concerning these and other risk factors is contained in Clover Health’s latest Annual Report on Form 10-K filed with the Securities and Exchange Commission (the “SEC”) on February 28, 2022, including the Risk Factors section therein, and in its other filings with the SEC. The forward-looking statements included in this release are made as of the date hereof. Except as required by law, Clover Health undertakes no obligation to update any of these forward-looking statements after the date of this response or to conform these statements to actual results or revised expectations.
The stocks have a year to date performance of -74.11 percent and weekly performance of -13.24 percent. The stock has been moved at -56.82 percent over the last six months. The stock has performed -24.77 percent around the most recent 30 days and changed -55.21 percent over the most recent 3-months.
If compared to the average trading volume of 7.39M shares, CLOV reached to a volume of 9037973 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Clover Health Investments Corp. [CLOV]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CLOV shares is $2.13 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CLOV stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Cowen have made an estimate for Clover Health Investments Corp. shares, keeping their opinion on the stock as Market Perform, with their previous recommendation back on February 02, 2022. While these analysts kept the previous recommendation, Canaccord Genuity raised their target price to Buy. The new note on the price target was released on February 02, 2022, representing the official price target for Clover Health Investments Corp. stock. Previously, the target price had yet another raise to $3, while SVB Leerink analysts kept a Mkt Perform rating on CLOV stock. On January 10, 2022, analysts decreased their price target for CLOV shares from 9 to 3.50.
The Average True Range (ATR) for Clover Health Investments Corp. is set at 0.09, with the Price to Sales ratio for CLOV stock in the period of the last 12 months amounting to 0.15. The Price to Book ratio for the last quarter was 1.17, with the Price to Cash per share for the same quarter was set at 1.54.
CLOV stock trade performance evaluation
Clover Health Investments Corp. [CLOV] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -13.24. With this latest performance, CLOV shares dropped by -24.77% in over the last four-week period, additionally sinking by -56.82% over the last 6 months – not to mention a drop of -77.02% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CLOV stock in for the last two-week period is set at 28.57, with the RSI for the last a single of trading hit 22.87, and the three-weeks RSI is set at 31.77 for Clover Health Investments Corp. [CLOV]. The present Moving Average for the last 50 days of trading for this stock 1.3609, while it was recorded at 1.0526 for the last single week of trading, and 2.3590 for the last 200 days.
Clover Health Investments Corp. [CLOV]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Clover Health Investments Corp. [CLOV] shares currently have an operating margin of -37.11. Clover Health Investments Corp.’s Net Margin is presently recorded at -38.21.
Return on Equity for this stock declined to -88.46, with Return on Assets sitting at -65.05.
Clover Health Investments Corp.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.30 and a Current Ratio set at 1.30.
Earnings per share (EPS) analysis for Clover Health Investments Corp. [CLOV] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CLOV. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Clover Health Investments Corp. go to 19.10%.
Clover Health Investments Corp. [CLOV]: Insider Ownership positions
There are presently around $119 million, or 32.50% of CLOV stock, in the hands of institutional investors. The top three institutional holders of CLOV stocks are: VANGUARD GROUP INC with ownership of 30,910,067, which is approximately -3.692% of the company’s market cap and around 3.10% of the total institutional ownership; BLACKROCK INC., holding 25,887,235 shares of the stock with an approximate value of $24.93 million in CLOV stocks shares; and STATE STREET CORP, currently with $7.85 million in CLOV stock with ownership of nearly 2.579% of the company’s market capitalization.
Positions in Clover Health Investments Corp. stocks held by institutional investors increased at the end of November and at the time of the November reporting period, where 83 institutional holders increased their position in Clover Health Investments Corp. [NASDAQ:CLOV] by around 9,658,498 shares. Additionally, 63 investors decreased positions by around 9,374,519 shares, while 55 investors held positions by with 104,248,400 shares. The mentioned changes placed institutional holdings at 123,281,417 shares, according to the latest SEC report filing. CLOV stock had 24 new institutional investments in for a total of 1,464,699 shares, while 24 institutional investors sold positions of 2,201,900 shares during the same period.